Laurent Pharmaceuticals provides clinical development update

Written By Caol

Laurent Pharmaceuticals announces positive outcomes of pre-planned interim DSMB safety review and futility analysis for phase 2 RESOLUTION study in hospitalized COVID-19 patients.

Read more here

Caol

Brand Identity Designer in Rhode Island

https://caol.design
Previous

Cherrystone Pitch Night
Next

Unruly released new research about Connected TV vs. Linear TV